E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/16/2006 in the Prospect News Biotech Daily.

TLC Vision maintained at market perform by JMP

JMP Securities analyst Anthony Ostrea kept TLC Vision Corp. at market perform. The company's shares rose after the company released its second-quarter earnings last week. According to the analyst, TLC's two growth initiatives (Truvision and LasikSelect) have not been ramping as expected. LasikSelect procedures per month were about 25%, behind expectations. Shares of the Mississauga, Ont.-based eye care services company were up 1 cent, or 0.20%, at $5.00, on volume of 182,159 shares versus the three-month running average of 210,095 shares. (Nasdaq: TLCV)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.